Navigation Links
Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
Date:7/11/2008

ng better evidence-based treatment options for patients."

Peginterferon alfa-2b is not approved for treatment of melanoma in either the US or EU.

About The Study

The study was designed to assess the efficacy and safety of long-term pegylated interferon alfa-2b vs. observation. Researchers randomised patients to either peginterferon alfa-2b adjuvant treatment (n=627) or observation only (n=629) within 70 days of regional lymph node dissection (intent-to-treat population). The endpoint was RFS. Participants randomized to pegylated interferon alfa-2b were to receive a dose of 6 micrograms/kg/week for an eight week induction phase followed by 3 micrograms/kg/wk (maintenance phase), for an intended total treatment duration of 5 years. Patients randomized to observation received no study treatment. The study results presented were analyzed by the EORTC.

Median RFS was 34.8 months and 25.6 months in the peginterferon alfa-2b and observation alfa-2b arms, respectively (difference of 9.2 months). The improvement in RFS was more pronounced in patients with a lower tumor burden in the lymph nodes based on predefined subgroups. For the subgroup of patients with clinically non-palpable (microscopic) lymph node disease, the HR for RFS was 0.73 (99 percent CI, 0.53-1.02, P=0.016, log-rank test) in favor of peginterferon alfa-2b treatment, as compared to 0.86 (99 percent CI, 0.68-1.10) in patients with clinically palpable nodes. Similarly, the HR in patients with one positive lymph node was 0.71 (99 percent CI, 0.53-0.97, P=0.004) as compared to 0.94 (99 percent CI, 0.73-1.21) in patients with more than one positive lymph node.

Peginterferon alfa-2b adjuvant treatment was not associated with a benefit on overall survival, a secondary endpoint, with a HR of 0.98 (95 percent CI, 0.82-1.16).

Grade 3 events occurred in 40 percent (246 patients) in the pegylated interferon alfa-2b arm versus 10 percent (60 patients) in the observational arm. Gra
'/>"/>

SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Patients Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
2. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
3. Pharmaxis Long-Term Safety Study of Bronchitol Completes
4. MultiVu Video Feed: Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA
5. Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R)
6. Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
7. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
8. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
9. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
10. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
11. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
(Date:8/21/2014)... 21, 2014 InfinityQS International, Inc., the ... Intelligence , today announces Infusion Chicago, its 9 ... be held Oct. 9-10, 2014, at the Chicago ... showcase the necessity for implementing a quality system ... Intelligence to gain insight into production processes. Complimentary ...
(Date:8/21/2014)... -- Professional Compounding Centers of America (PCCA) will ... three best scientific presentations at the sixth ... Formulating Better Medicines for Children  conference, held ... Greece , includes dozens of poster-style scientific ... three winners will be selected by a panel ...
Breaking Medicine Technology:Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2
... Food and Drug Administration today allowed marketing of the first ... dengue fever or dengue hemorrhagic fever, a leading cause of ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The dengue ... infected Aedes mosquito. As many as 100 million ...
... 2011 The U.S. Food and Drug Administration today cleared ... assay that is designed to rapidly detect the toxin B ... cause of diarrhea that can lead to colitis, other serious ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Clostridium difficile ( ...
Cached Medicine Technology:FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 2FDA Permits Marketing of First Test to Help Diagnose Dengue Fever 3FDA Clears Test for Bacteria That Can Cause Serious Intestinal Disease 2
(Date:8/21/2014)... by T-type calcium channels in the thalamic reticular ... calcium. These channels enable thalamic reticular nucleus neurons ... enter a hyper-excited state. , In order to ... seizures, the researchers conducted an experiment to induce ... to delete the T-type calcium channel CaV3.3. The ...
(Date:8/21/2014)... August 21, 2014 ... Peripheral Vascular Devices Market by Angioplasty ... Catheter (IVUS, OCT), IVC Filter (Retrievable), ... 2018" analyzes and studies the major ... the U.S. and Canada. , Browse ...
(Date:8/21/2014)... 21, 2014 mynt welcomes industry leaders ... to join its growing company. Since its pre-launch in ... product sales and continues to gain momentum leading up ... Rob and Tiffanie came into network marketing by chance. ... number of network marketing companies. Tiffanie needed help at ...
(Date:8/21/2014)... 21, 2014 One of the emerging trends ... ostomy drainage bags. This increases the availability and accessibility of ... forecast the Global Ostomy Care Accessories market to ... 2013-2018. According to the report, the Global Ostomy Care Accessories ... is one of the major drivers. The number of procedures ...
(Date:8/21/2014)... Raleigh, NC (PRWEB) August 21, 2014 ... proteins produced by Staph bacteria has been used to ... just posted an article on the new research. ... at the University of Western Australia treated mesothelioma ... that it killed the cancer cells while simultaneously stimulating ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 2Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 3Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 4Health News:North American Interventional Cardiology and Peripheral Vascular Devices Market worth $5.9 Billion by 2018 - Research Report by MarketsandMarkets 5Health News:Industry Leaders Rob and Tiffanie Moffitt Join mynt 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Ostomy Care Accessories Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Study Finds Bacteria Compound Shrinks Mesothelioma Tumors, According to Surviving Mesothelioma 2
... , , DALLAS ... PHNS Inc. announced its,new "24/7 Claims Acceleration" services for U.S. ... and China -based IT and business,process outsourcing provider iSoftStone. ... in Tianjin, China . All of this,new team have ...
... Ariz. , Feb. 9 Cancer Clinics of ... oncologists has announced the addition of The West Clinic, ... http://www.newscom.com/cgi-bin/prnh/20080612/AQTH094LOGO ) , "CCE is very pleased to welcome The ... Pennsylvania Oncology, Philadelphia, PA and Chairman of CCE. ...
... , KNOXVILLE, Tenn. , Feb. 9 Team ... the largest suppliers of outsourced healthcare professional staffing and administrative services ... , today announced results for its fourth quarter and full fiscal ... be a landmark quarter for TeamHealth, and we are pleased to ...
... , BOCA RATON, Fla. , Feb. 9 ... and Prevention, nearly one in four women in the United ... or boyfriend at some point in her life. Another startling statistic ... in 5 Canadian teens experience dating violence. , (Photo:   http://www.newscom.com/cgi-bin/prnh/20100209/LA52551 ...
... , Feb. 9 International Planned Parenthood ... and Young People in the 21st Century," advocates policies ... of parents and the moral values of our society, ...  ) , The report promotes contraceptive sex education ...
... STATESVILLE, N.C. , Feb. 9 Jimmy Johnson ... excellence! No, not the four-time Sprint Cup champion Jimmie Johnson, ... host. , The newly named ExtenZe spokesman and star of the ... Speedway on Sunday, Feb. 14 , the day of the Daytona ...
Cached Medicine News:Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 2Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 3Health News:PHNS Implements New Accelerated Claims Resolution Services With iSoftStone 4Health News:The West Clinic Joins Cancer Clinics of Excellence (CCE) 2Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 2Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 3Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 4Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 5Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 6Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 7Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 8Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 9Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 10Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 11Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 12Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 13Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 14Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 15Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 16Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 17Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 18Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 19Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 20Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 21Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 22Health News:Team Health Holdings, Inc., Announces Fourth Quarter and Fiscal 2009 Financial Results 23Health News:ADT Safety Tips: Personal Safety 2Health News:ADT Safety Tips: Personal Safety 3Health News:ADT Safety Tips: Personal Safety 4Health News:Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority 2Health News:Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona 2Health News:Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona 3
The Model 273 is a general purpose instrument with output that may be either DC-coupled for very slow changes such as venous occlusion and penile tumescence studies or AC-coupled for respiratory or p...
... Plastic and fabric specialty drapes ... gynecology. Steri-Drape absorbent prevention fabric ... fluid strike-through reducing the need ... Drape Pack, Op tape, Hand ...
... top design takes into account a wide ... flexible working environment for the surgical team. ... be matched exactly to your patients height. ... creates superior access for image amplification procedures. ...
... Mitek is the Market leader in soft ... Suture, DePuy Mitek has developed the latest ... open shoulder repair. ORTHOCORD Suture is as ... the market. Most importantly, ORTHOCORD Suture handles ...
Medicine Products: